全文获取类型
收费全文 | 7894篇 |
免费 | 740篇 |
国内免费 | 255篇 |
专业分类
耳鼻咽喉 | 77篇 |
儿科学 | 41篇 |
妇产科学 | 190篇 |
基础医学 | 381篇 |
口腔科学 | 337篇 |
临床医学 | 1029篇 |
内科学 | 1145篇 |
皮肤病学 | 35篇 |
神经病学 | 361篇 |
特种医学 | 308篇 |
外科学 | 1124篇 |
综合类 | 1148篇 |
一般理论 | 1篇 |
预防医学 | 368篇 |
眼科学 | 65篇 |
药学 | 754篇 |
2篇 | |
中国医学 | 227篇 |
肿瘤学 | 1296篇 |
出版年
2024年 | 12篇 |
2023年 | 177篇 |
2022年 | 305篇 |
2021年 | 449篇 |
2020年 | 421篇 |
2019年 | 413篇 |
2018年 | 385篇 |
2017年 | 438篇 |
2016年 | 395篇 |
2015年 | 341篇 |
2014年 | 711篇 |
2013年 | 624篇 |
2012年 | 561篇 |
2011年 | 592篇 |
2010年 | 457篇 |
2009年 | 429篇 |
2008年 | 384篇 |
2007年 | 359篇 |
2006年 | 285篇 |
2005年 | 227篇 |
2004年 | 169篇 |
2003年 | 123篇 |
2002年 | 94篇 |
2001年 | 90篇 |
2000年 | 94篇 |
1999年 | 71篇 |
1998年 | 56篇 |
1997年 | 39篇 |
1996年 | 33篇 |
1995年 | 33篇 |
1994年 | 20篇 |
1993年 | 22篇 |
1992年 | 6篇 |
1991年 | 15篇 |
1990年 | 6篇 |
1989年 | 13篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1985年 | 9篇 |
1984年 | 3篇 |
1983年 | 7篇 |
1982年 | 1篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1977年 | 1篇 |
排序方式: 共有8889条查询结果,搜索用时 500 毫秒
1.
2.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
3.
4.
目的 探究高龄产妇产后抑郁的影响因素,为护理人员今后在临床工作中提供个性化的护理服务提供参考依据。方法 采用质性研究中的现象学研究法对2021年12月至2022年4月在内蒙古医科大学附属医院妇产科建档分娩的16例高龄产妇进行半结构式访谈,并以Colaizzi现象学研究方法进行资料分析。结果 提炼出影响高龄产妇产后抑郁的4个主题:躯体性压力源;负性心理体验;社会支持缺乏,矛盾出现;角色转变对高龄产妇的影响。结论 需重视高龄产妇产后的主观感受,加强产前产后健康宣教,构建以家庭为中心的高龄产妇产后护理模型,减少产后抑郁的发生。 相似文献
5.
《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2019,13(2):1225-1229
Background and objectivesThe present review shows a list of anti-glycation plants with their anti-glycation activity mechanisms that can attract the attention of pharmacologist for further scientific research towards finding better remedy for diabetic complications.MaterialsGoogle scholar, Pubmed, Web of Science and Scopus were searched. The terms were advanced glycation end products (AGEs), medicinal plants, antiglycation products.Resultsplants that studied in this review inhibit glycation in several possible mechanisms. Some of these plants inhibit the production of shiff base and amadori products. The others inhibit the generation of amadori products in the advanced phase. Some others blocked the aggregation of AGEs and some plants have antioxidant activity and reduce AGEs formation by preventing oxidation of amadori product and metal-catalyzed glucoxidation.ConclusionThis review can help pharmacologist to find antiglycation natural substance that can be useful in treatment of diabetic complications. 相似文献
6.
7.
目的探索阿帕替尼治疗晚期及术后复发肺肉瘤样癌的疗效。方法收集2016年6月至2019年8月Ⅲ~Ⅳ期及术后复发的肺肉瘤样癌患者21例,口服阿帕替尼(250~425 mg/d)治疗,30 d为1个疗程,观察并分析疗效及评价安全性。结果21例患者中,完全缓解(CR)为0,部分缓解(PR)为14.3%(3例),稳定(SD)为33.3%(7例),疾病进展(PD)为52.4%(11例);客观反应率(ORR)为13.3%(3例),疾病控制率(DCR)为47.6%(10例)。中位总生存期(mOS)为4.6个月,中位无进展生存期(mPFS)为1.0个月。病灶≥6 cm(或≥5 cm)较<6 cm(或<5 cm)平均OS明显缩短,差异有统计学意义(P<0.05);术后分期Ⅰ~Ⅱ期较Ⅲ~Ⅳ期平均OS明显延长(P<0.05)。位于中央的病灶较周围的病灶平均OS明显缩短,差异有统计学意义(P<0.01)。性别、年龄(>60岁,≤60岁)、吸烟史(是/否)对疗效影响差异无统计学意义。常见不良反应包括高血压38.1%(8例)、蛋白尿23.8%(5例)、手足综合征28.6%(6例)、腹泻28.6(6例)、骨髓抑制38.1%(8例)。结论阿帕替尼治疗晚期及术后复发肺肉瘤样癌具有一定疗效,不良反应可控,病灶大小、位置及分期可能是疗效的独立影响因素。 相似文献
8.
9.
《介入医学杂志(英文)》2021,4(4):159-171
Pancreatic cancer has become a major disease affecting people's health because of its insidiousness, rapid progression and poor prognosis. Based on the practical needs of clinical work, combined with domestic multi-center research and experience, this guideline provides constructive suggestions for the interventional treatment of pancreatic cancer. 相似文献
10.